Consulter en ligne

Suggestions

Du même auteur

Multiple sequence variants of BRCA2 exon 7 alter splicing regulation

Archive ouverte | Gaildrat, Pascaline | CCSD

International audience

Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx).

Archive ouverte | Bruera, Gemma | CCSD

International audience. BACKGROUND: Prognosis of KRAS wild-type and mutant metastatic colorectal cancer (MCRC) patients (pts) treated with bevacizumab (BEV)-containing chemotherapy is not significantly different. Si...

Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease.

Archive ouverte | Bruera, Gemma | CCSD

International audience. ABSTRACT: BACKGROUND: Bevacizumab (BEV) plus triplet chemotherapy can increase efficacy of first-line treatment of metastatic colorectal cancer (MCRC), particularly integrated with secondary ...

Chargement des enrichissements...